Fig. 2: Overall survival and leukemia transformation rate according to the revised International Prognostic Scoring System (IPSS-R) risk categories and mutational status. | Blood Cancer Journal

Fig. 2: Overall survival and leukemia transformation rate according to the revised International Prognostic Scoring System (IPSS-R) risk categories and mutational status.

From: Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Fig. 2

a–d Overall survival according to the presence or absence of poor-risk mutations (CBL, IDH2, ASXL1, DNMT3A, and TP53 mutations) and IPSS-R. e–h Leukemia transformation rate according to the presence or absence of poor-risk mutations (CBL, IDH2, ASXL1, DNMT3A, and TP53 mutations) and IPSS-R

Back to article page